FR2850864B1 - Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres - Google Patents

Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres

Info

Publication number
FR2850864B1
FR2850864B1 FR0350023A FR0350023A FR2850864B1 FR 2850864 B1 FR2850864 B1 FR 2850864B1 FR 0350023 A FR0350023 A FR 0350023A FR 0350023 A FR0350023 A FR 0350023A FR 2850864 B1 FR2850864 B1 FR 2850864B1
Authority
FR
France
Prior art keywords
phanes
skin
dehydrogenase inhibitor
prostaglandin dehydrogenase
hydroxy prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0350023A
Other languages
English (en)
Other versions
FR2850864A1 (fr
Inventor
Jean Francois Michelet
Stephane Commo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0350023A priority Critical patent/FR2850864B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to JP2006500159A priority patent/JP4584908B2/ja
Priority to EP04710409.6A priority patent/EP1594438B1/fr
Priority to ES04710409T priority patent/ES2429894T3/es
Priority to CNB2004800097213A priority patent/CN100393299C/zh
Priority to PCT/FR2004/000325 priority patent/WO2004073594A2/fr
Priority to CA002515440A priority patent/CA2515440A1/fr
Publication of FR2850864A1 publication Critical patent/FR2850864A1/fr
Priority to US11/202,192 priority patent/US7705041B2/en
Application granted granted Critical
Publication of FR2850864B1 publication Critical patent/FR2850864B1/fr
Priority to JP2010025811A priority patent/JP2010100659A/ja
Priority to US12/706,730 priority patent/US8735445B2/en
Priority to JP2013269231A priority patent/JP5897539B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
FR0350023A 2003-02-12 2003-02-12 Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres Expired - Fee Related FR2850864B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0350023A FR2850864B1 (fr) 2003-02-12 2003-02-12 Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
EP04710409.6A EP1594438B1 (fr) 2003-02-12 2004-02-12 Utilisation d'un inhibiteur de 15-hydroxy prostaglandine déshydrogénase pour favoriser la pigmentation de la peau ou des phanères
ES04710409T ES2429894T3 (es) 2003-02-12 2004-02-12 Utilización de un inhibidor de 15-hidroxi prostaglandina deshidrogenasa para favorecer la pigmentación de la piel o de las faneras
CNB2004800097213A CN100393299C (zh) 2003-02-12 2004-02-12 15-羟基前列腺素脱氢酶抑制剂刺激皮肤或皮肤附属物着色的用途
PCT/FR2004/000325 WO2004073594A2 (fr) 2003-02-12 2004-02-12 Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
CA002515440A CA2515440A1 (fr) 2003-02-12 2004-02-12 Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
JP2006500159A JP4584908B2 (ja) 2003-02-12 2004-02-12 皮膚または皮膚付属物の色素沈着を刺激するための１５−ヒドロキシプロスタグランジンデヒドロゲナーゼの阻害剤の使用
US11/202,192 US7705041B2 (en) 2003-02-12 2005-08-12 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages
JP2010025811A JP2010100659A (ja) 2003-02-12 2010-02-08 皮膚または皮膚付属物の色素沈着を刺激するための１５−ヒドロキシプロスタグランジンデヒドロゲナーゼの阻害剤の使用
US12/706,730 US8735445B2 (en) 2003-02-12 2010-02-17 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages
JP2013269231A JP5897539B2 (ja) 2003-02-12 2013-12-26 皮膚または皮膚付属物の色素沈着を刺激するための１５−ヒドロキシプロスタグランジンデヒドロゲナーゼの阻害剤の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0350023A FR2850864B1 (fr) 2003-02-12 2003-02-12 Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres

Publications (2)

Publication Number Publication Date
FR2850864A1 FR2850864A1 (fr) 2004-08-13
FR2850864B1 true FR2850864B1 (fr) 2007-04-13

Family

ID=32732076

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0350023A Expired - Fee Related FR2850864B1 (fr) 2003-02-12 2003-02-12 Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres

Country Status (3)

Country Link
CN (1) CN100393299C (fr)
ES (1) ES2429894T3 (fr)
FR (1) FR2850864B1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050058614A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
US7070768B2 (en) 2003-09-25 2006-07-04 Allergan, Inc. Method for imparting artificial tan to human skin
FR2887441A1 (fr) * 2005-06-26 2006-12-29 Oreal Utilisation de composes benzyl-1,3-thiazolidine-2,4-diones pour favoriser et/ou induire et/ou stimuler la pigmentation des matieres keratiniques et/ou limiter leur depigmentation et/ou leur blanchiment.
FR2887442A1 (fr) * 2005-06-28 2006-12-29 Oreal Composes benzyl-1,3-thiazolidine-2,4-diones, leurs utilisations et compositions pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute
FR2887443A1 (fr) * 2005-06-28 2006-12-29 Oreal Utilisation de composes benzylidene-1,3-thiazolidine-2,4- diones pour favoriser et/ou induire et/ou stimuler la pigmentation des matieres keratiniques et/ou limiter leur depigmentation et/ou leur blanchement.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653983A (en) * 1991-07-19 1997-08-05 Lvmh Recherche Compositions for the pigmentation of the skin or of the hair containing an extract of Marrubium vulgare, the process for it's manufacture and it's
FR2684300B1 (fr) * 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
CA2159626C (fr) * 1993-04-02 2001-10-02 Lingna Li Methode pour delivrer des compositions benefiques aux follicules pileux
EP0812210A4 (fr) * 1995-02-23 1998-08-19 Life Medical Sciences Inc Compositions et procedes pour ameliorer la croissance des cheveux et pour leur restituer leur couleur d'origine
EP0884045A1 (fr) * 1997-06-06 1998-12-16 Pfizer Products Inc. Formulations autobronzantes de dihydroxyacetone à stabilité améliorée et conférant une administration accrue
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6267948B1 (en) * 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
AU7360700A (en) * 1999-09-09 2001-04-10 Androsolutions, Inc. Methods and compositions for preventing and treating urinary tract disorders
FR2807323A1 (fr) * 2000-04-10 2001-10-12 Oreal Composition, notamment cosmetique, renfermant un steroide et un 2-alkyl alcanol ou un ester

Also Published As

Publication number Publication date
FR2850864A1 (fr) 2004-08-13
CN100393299C (zh) 2008-06-11
CN1774229A (zh) 2006-05-17
ES2429894T3 (es) 2013-11-18

Similar Documents

Publication Publication Date Title
PT1144368E (pt) Sulfonamidas acetilenicas de acidos hidroxamicos baseados em alfa-aminoacidos como inibidores de tace
DE60101991D1 (de) Gleichstrom- zu Gleichstromumwandler
DE60332798D1 (de) Verringerung des Verhältnisses von Spitzen- zu Durchschnittsleistung
FR2894961B1 (fr) Utilisation de ceramides pour depigmenter la peau
WO2003077856A3 (fr) Compositions de lotion
FR2903902B1 (fr) Utilisation d'une composition cosmetique pour favoriser la depigmentation cutanee.
FR2841781B1 (fr) Utilisation de peptides pour favoriser la regeneration cutannee
FR2813188B1 (fr) Utilisation de la tyramine dans des compositions cosmetiques destinees a eclaicir la peau
FR2850864B1 (fr) Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
FR2849597B1 (fr) Composition cosmetique pour le soin des peaux grasses, contenant un acide gras carboxylique ou l'un de ses derives
FR2947448B1 (fr) Utilisation d'un compose d'acide jasmonique pour traiter la peau grasse
FR2887447B1 (fr) Utilisation d'un peptide comme principe actif amincissant
FR2920303B1 (fr) Utilisation d'un extrait de boerhavia pour apaiser la peau.
FR2928090B1 (fr) Utilisation d'un extrait de l'orchidee vanda coerulea comme agent hydratant de la peau
FR2851916B1 (fr) Utilisation de polyphenols catechiques pour la preparation de compositions destinees a favoriser la pigmentation naturelles de la peau
FR2866562B1 (fr) Utilisation d'un tetrapolymere acrylique comme agent tenseur de la peau.
FR2905857B1 (fr) Utilisation d'un extrait de pulpe de caroube pour hydrate la peau
FR2885803B1 (fr) Utilisation cosmetique de la vitamine k comme enlumineur naturel de la peau ou des levres
FR2839453B1 (fr) Utilisation de novirhabdovirus modifies pour l'obtention de vaccins
FR2811556B1 (fr) Composition comprenant un precurseur de ceramides, utilisation pour ameliorer l'epiderme naturel ou reconstruit , equivalent de peau obtenu
FR2837702B1 (fr) Composition cosmetique pour le soin de la peau plus particulierement comme soin de nuit
FR2876374B1 (fr) Utilisation d'esters phosphoriques comme agents anti-depots lors de la synthese, la purification ou la regeneration de monomeres (meth) acryliques
FR2885052B1 (fr) Utilisation d'un extrait de maca pour proteger la microcirculation cutanee
FR2931669B1 (fr) Utilisation de derives d'hydroxyalkylsufone a titre d'agent hydratant de la peau.
FR2864540B1 (fr) Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase-related-protein 1 comme agents depigmentants

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20181031